封面
市場調查報告書
商品編碼
1609169

下一代定序 CLIA 實驗室服務市場:按技術、驗證類型、應用和最終用戶 - 2025-2030 年全球預測

Next Generation Sequencing CLIA Laboratory Services Market by Technology, Certificate Types, Application, End-users - Global Forecast 2025-2030

出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年下一代定序CLIA實驗室服務市場規模為58.1億美元,預計2024年將達到67.8億美元,複合年成長率為13.97%,2030年將達到145.2億美元,預計將達到1000萬美元。

次世代定序(NGS) CLIA化驗服務是臨床診斷的重要領域,它將最先進的定序技術與嚴格的實驗室標準結合。 CLIA(臨床實驗室改進修正案)認證確保這些實驗室符合高品質的檢測通訊協定,從而確保患者檢測結果的準確性、可靠性和及時性。 NGS CLIA化驗服務的需求在於提供全面的基因定序的能力,以支持早期疾病檢測、個人化醫療以及針對個人基因圖譜量身定做的治療策略。其應用範圍包括癌症基因組、遺傳疾病檢測、感染疾病分析和藥物基因組學。典型的最終用戶包括醫院、學術研究機構、診斷實驗室和製藥公司。顯著的市場成長促進因素包括遺傳疾病和癌症盛行率上升、NGS 技術進步帶來的成本降低以及個人化醫療需求的增加。最近的機會包括將人工智慧用於基因組學資料分析、擴展到農村和服務不足的醫療保健環境,以及透過戰略夥伴關係關係滲透國際市場。然而,與基因檢測相關的倫理問題、設備和營運成本較高的初始投資以及嚴格的法規環境等因素對市場成長構成了挑戰。此外,資料隱私問題和報銷限制仍然是重大障礙。儘管如此,創新和研究的最佳領域包括開發更有效率的生物資訊工具和平台、提高定序準確性和速度以及探索非侵入性檢測方法。此外,跨部門夥伴關係有可能擴大 NGS 在新治療領域的效用。該市場的特點是技術進步快、競爭激烈,需要持續創新和策略行銷才能有效獲得和維持市場佔有率。為了在這個充滿活力的環境中蓬勃發展,我們鼓勵公司投資研發、策略聯盟,並提供豐富的服務組合,以滿足廣泛的醫療保健需求。

主要市場統計
基準年[2023] 58.1億美元
預測年份 [2024] 67.8億美元
預測年份 [2030] 145.2億美元
複合年成長率(%) 13.97%

市場動態:快速發展的下一代定序 CLIA 實驗室服務市場的關鍵市場洞察

供需的動態交互作用正在改變下一代定序 CLIA 實驗室服務市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險,同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 傳染性和非傳染性疾病的迅速增加以及對診斷測試的需求
    • 越來越多的政府專注於加強疾病篩檢和監測能力
    • 增加對癌症研究的研究和投資
  • 市場限制因素
    • 診斷中心缺乏熟練的專業人員
  • 市場機會
    • 利用 NGS 提高基因組分析的臨床效用與有效性
    • 新一代定序技術的技術進步
  • 市場挑戰
    • 生物資訊學和計算技術的複雜性不斷增加

波特五力:引領次世代定序 CLIA 實驗室服務市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢、解決弱點並避免潛在的挑戰,以確保更強大的市場地位。

PESTLE分析:了解下一代定序 CLIA 實驗室服務市場的外部影響

外部宏觀環境因素在塑造下一代定序 CLIA 實驗室服務市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素,公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化,並幫助他們做出積極主動的決策。

市場佔有率分析 了解下一代定序 CLIA 實驗室服務市場的競爭格局

下一代定序 CLIA 實驗室服務市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢,為供應商提供了製定策略決策所需的洞察力,使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣次世代定序 CLIA 實驗室服務市場供應商的績效評估

FPNV 定位矩陣是評估下一代定序 CLIA 實驗室服務市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商,從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商,以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了下一代定序 CLIA 實驗室服務市場的成功之路

下一代定序 CLIA 實驗室服務市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過考慮關鍵資源、能力和績效指標,公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰,利用新的商機並取得長期成功。

本報告對市場進行了全面分析,涵蓋關鍵重點領域:

1. 市場滲透率:詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓:辨識新興市場的成長機會,評估現有領域的擴張潛力,並提供未來成長的策略藍圖。

3. 市場多元化:分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報:徹底分析競爭格局,檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新:重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題,幫助相關人員做出明智的決策:

1.目前的市場規模和未來的成長預測是多少?

2. 哪些產品、區隔市場和地區提供最佳投資機會?

3.塑造市場的主要技術趨勢和監管影響是什麼?

4.主要廠商的市場佔有率和競爭地位如何?

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼?

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 傳染性和非傳染性疾病的增加以及對診斷測試的需求
      • 政府專注於加強疾病檢測和監測能力
      • 增加對癌症研究的研究和投資
    • 抑制因素
      • 診斷中心缺乏熟練的專業人員
    • 機會
      • 利用 NGS 提高基因組分析的臨床效用與有效性
      • 次世代定序技術的技術進步
    • 任務
      • 生物資訊學和技術中的計算複雜性
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第 6 章 下一代定序 CLIA 實驗室服務市場:依技術分類

  • 遊離DNA定序
  • 元基因組定序
  • NGS基因組定序
  • 標靶定序和定序
  • 全EXOME定序
  • 全基因組序列分析

第 7 章按證書類型分類的下一代定序 CLIA 實驗室服務市場

  • 醫護人員進行的顯微鏡檢查證明
  • 證書
  • 合格證書
  • 註冊證書
  • 豁免證明書

第 8 章下一代定序 CLIA 實驗室服務市場:依應用分類

  • 生物標記發現
  • 診斷
  • 藥物發現
  • 精準醫療

第 9 章 下一代定序 CLIA 實驗室服務市場:按最終用戶

  • 診斷中心
  • 醫院

第 10 章 美洲次世代定序 CLIA 實驗室服務市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太地區次世代定序CLIA實驗室服務市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲的下一代定序 CLIA 實驗室服務市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣,2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Agilent Technologies, Inc.
  • Azenta Life Sciences
  • Beijing Genomics Co. Ltd.
  • Bio-Rad Laboratories, Inc.
  • BioMerieux SA
  • Charles River Laboratories, Inc.
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche AG
  • Illumina, Inc.
  • Macrogen, Inc.
  • NanoString Technologies, Inc.
  • Perkin Elmer, Inc.
  • PierianDx, Inc.
  • Pillar Biosciences, Inc.
  • Qiagen NV
  • Saphetor SA
  • Takara Bio Inc.
  • Thermo Fisher Scientific, Inc.
Product Code: MRR-C41945B3D381

The Next Generation Sequencing CLIA Laboratory Services Market was valued at USD 5.81 billion in 2023, expected to reach USD 6.78 billion in 2024, and is projected to grow at a CAGR of 13.97%, to USD 14.52 billion by 2030.

Next Generation Sequencing (NGS) CLIA Laboratory Services represent a pivotal area in clinical diagnostics, combining cutting-edge sequencing technologies with rigorous laboratory standards. The Clinical Laboratory Improvement Amendments (CLIA) certification ensures that these labs meet high-quality testing protocols, thereby assuring accuracy, reliability, and timeliness of patient test results. The necessity of NGS CLIA lab services lies in their ability to offer comprehensive genetic sequencing that aids in early disease detection, personalized medicine, and treatment strategies tailored to individual genetic profiles. Their application spans cancer genomics, hereditary disease testing, infectious disease analysis, and pharmacogenomics. Key end-users include hospitals, academic research institutes, diagnostic laboratories, and pharmaceutical companies. Notably, factors driving market growth include the rising prevalence of genetic disorders and cancer, advancements in NGS technology reducing costs, and the increasing demand for personalized medicine. Recent opportunities highlight the integration of artificial intelligence for data analytics in genomics, expansion into rural and underserved healthcare settings, and international market penetration through strategic partnerships. However, market growth is challenged by factors such as ethical concerns related to genetic testing, significant initial investment for equipment and operational costs, and a stringent regulatory environment. Furthermore, data privacy issues and reimbursement constraints remain salient barriers. Nonetheless, the best areas for innovation and research include developing more efficient bioinformatics tools and platforms, improving sequencing accuracy and speed, and exploring non-invasive testing methods. Additionally, cross-disciplinary partnerships could expand the utility of NGS in new therapeutic areas. The market is characterized by rapid technological advancements and intense competition, necessitating continuous innovation and strategic marketing to capture and retain market share effectively. Companies are advised to invest in R&D and strategic collaborations to excel in this dynamic environment, offering enriched service portfolios that cater to a broad array of healthcare needs.

KEY MARKET STATISTICS
Base Year [2023] USD 5.81 billion
Estimated Year [2024] USD 6.78 billion
Forecast Year [2030] USD 14.52 billion
CAGR (%) 13.97%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Next Generation Sequencing CLIA Laboratory Services Market

The Next Generation Sequencing CLIA Laboratory Services Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Proliferation of communicable and noncommunicable disorders and need for diagnostic testing
    • Increasing government focus on enhancing disease screening and monitoring capabilities
    • Rising research and investments in cancer research
  • Market Restraints
    • Limited availability of skilled professionals in diagnostic centers
  • Market Opportunities
    • Improvements in clinical utility and efficacy of genomic profiling with the NGS
    • Technological advances in next generation sequencing technologies
  • Market Challenges
    • Bioinformatics and computational complications in technology

Porter's Five Forces: A Strategic Tool for Navigating the Next Generation Sequencing CLIA Laboratory Services Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Next Generation Sequencing CLIA Laboratory Services Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Next Generation Sequencing CLIA Laboratory Services Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Next Generation Sequencing CLIA Laboratory Services Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Next Generation Sequencing CLIA Laboratory Services Market

A detailed market share analysis in the Next Generation Sequencing CLIA Laboratory Services Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Next Generation Sequencing CLIA Laboratory Services Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Next Generation Sequencing CLIA Laboratory Services Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Next Generation Sequencing CLIA Laboratory Services Market

A strategic analysis of the Next Generation Sequencing CLIA Laboratory Services Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Next Generation Sequencing CLIA Laboratory Services Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Azenta Life Sciences, Beijing Genomics Co. Ltd., Bio-Rad Laboratories, Inc., BioMerieux S.A., Charles River Laboratories, Inc., Eurofins Scientific SE, F. Hoffmann-La Roche AG, Illumina, Inc., Macrogen, Inc., NanoString Technologies, Inc., Perkin Elmer, Inc., PierianDx, Inc., Pillar Biosciences, Inc., Qiagen N.V., Saphetor SA, Takara Bio Inc., and Thermo Fisher Scientific, Inc..

Market Segmentation & Coverage

This research report categorizes the Next Generation Sequencing CLIA Laboratory Services Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Technology, market is studied across Cell Free DNA Sequencing, Metagenomic Sequencing, NGS Gene Panel Sequencing, Targeted Sequencing & Re-sequencing, Whole Exome Sequencing, and Whole Genome Sequencing.
  • Based on Certificate Types, market is studied across Certificate for Provider-Performed Microscopy Procedures, Certificate of Accreditation, Certificate of Compliance, Certificate of Registration, and Certificate of Waiver.
  • Based on Application, market is studied across Biomarker Discovery, Diagnostics, Drug Discovery, and Precision Medicine.
  • Based on End-users, market is studied across Diagnostic Centers and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Proliferation of communicable and noncommunicable disorders and need for diagnostic testing
      • 5.1.1.2. Increasing government focus on enhancing disease screening and monitoring capabilities
      • 5.1.1.3. Rising research and investments in cancer research
    • 5.1.2. Restraints
      • 5.1.2.1. Limited availability of skilled professionals in diagnostic centers
    • 5.1.3. Opportunities
      • 5.1.3.1. Improvements in clinical utility and efficacy of genomic profiling with the NGS
      • 5.1.3.2. Technological advances in next generation sequencing technologies
    • 5.1.4. Challenges
      • 5.1.4.1. Bioinformatics and computational complications in technology
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Next Generation Sequencing CLIA Laboratory Services Market, by Technology

  • 6.1. Introduction
  • 6.2. Cell Free DNA Sequencing
  • 6.3. Metagenomic Sequencing
  • 6.4. NGS Gene Panel Sequencing
  • 6.5. Targeted Sequencing & Re-sequencing
  • 6.6. Whole Exome Sequencing
  • 6.7. Whole Genome Sequencing

7. Next Generation Sequencing CLIA Laboratory Services Market, by Certificate Types

  • 7.1. Introduction
  • 7.2. Certificate for Provider-Performed Microscopy Procedures
  • 7.3. Certificate of Accreditation
  • 7.4. Certificate of Compliance
  • 7.5. Certificate of Registration
  • 7.6. Certificate of Waiver

8. Next Generation Sequencing CLIA Laboratory Services Market, by Application

  • 8.1. Introduction
  • 8.2. Biomarker Discovery
  • 8.3. Diagnostics
  • 8.4. Drug Discovery
  • 8.5. Precision Medicine

9. Next Generation Sequencing CLIA Laboratory Services Market, by End-users

  • 9.1. Introduction
  • 9.2. Diagnostic Centers
  • 9.3. Hospitals

10. Americas Next Generation Sequencing CLIA Laboratory Services Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Next Generation Sequencing CLIA Laboratory Services Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Next Generation Sequencing CLIA Laboratory Services Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Agilent Technologies, Inc.
  • 2. Azenta Life Sciences
  • 3. Beijing Genomics Co. Ltd.
  • 4. Bio-Rad Laboratories, Inc.
  • 5. BioMerieux S.A.
  • 6. Charles River Laboratories, Inc.
  • 7. Eurofins Scientific SE
  • 8. F. Hoffmann-La Roche AG
  • 9. Illumina, Inc.
  • 10. Macrogen, Inc.
  • 11. NanoString Technologies, Inc.
  • 12. Perkin Elmer, Inc.
  • 13. PierianDx, Inc.
  • 14. Pillar Biosciences, Inc.
  • 15. Qiagen N.V.
  • 16. Saphetor SA
  • 17. Takara Bio Inc.
  • 18. Thermo Fisher Scientific, Inc.

LIST OF FIGURES

  • FIGURE 1. NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET RESEARCH PROCESS
  • FIGURE 2. NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CELL FREE DNA SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY METAGENOMIC SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY NGS GENE PANEL SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TARGETED SEQUENCING & RE-SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY WHOLE EXOME SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE FOR PROVIDER-PERFORMED MICROSCOPY PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE OF ACCREDITATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE OF COMPLIANCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE OF REGISTRATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE OF WAIVER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY BIOMARKER DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY PRECISION MEDICINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 60. AUSTRALIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
  • TABLE 61. AUSTRALIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. AUSTRALIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 63. CHINA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 64. CHINA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
  • TABLE 65. CHINA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. CHINA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 67. INDIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 68. INDIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
  • TABLE 69. INDIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. INDIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 71. INDONESIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 72. INDONESIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
  • TABLE 73. INDONESIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. INDONESIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 75. JAPAN NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 76. JAPAN NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
  • TABLE 77. JAPAN NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. JAPAN NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 79. MALAYSIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 80. MALAYSIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
  • TABLE 81. MALAYSIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. MALAYSIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 83. PHILIPPINES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 84. PHILIPPINES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
  • TABLE 85. PHILIPPINES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. PHILIPPINES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 87. SINGAPORE NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 88. SINGAPORE NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
  • TABLE 89. SINGAPORE NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. SINGAPORE NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH KOREA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 92. SOUTH KOREA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
  • TABLE 93. SOUTH KOREA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. SOUTH KOREA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 95. TAIWAN NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 96. TAIWAN NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
  • TABLE 97. TAIWAN NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. TAIWAN NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 99. THAILAND NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 100. THAILAND NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
  • TABLE 101. THAILAND NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. THAILAND NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 103. VIETNAM NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 104. VIETNAM NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
  • TABLE 105. VIETNAM NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. VIETNAM NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 112. DENMARK NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 113. DENMARK NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
  • TABLE 114. DENMARK NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. DENMARK NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 116. EGYPT NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 117. EGYPT NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
  • TABLE 118. EGYPT NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. EGYPT NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 120. FINLAND NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 121. FINLAND NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
  • TABLE 122. FINLAND NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. FINLAND NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 124. FRANCE NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 125. FRANCE NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
  • TABLE 126. FRANCE NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. FRANCE NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 128. GERMANY NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 129. GERMANY NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
  • TABLE 130. GERMANY NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. GERMANY NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 132. ISRAEL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 133. ISRAEL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
  • TABLE 134. ISRAEL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. ISRAEL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 136. ITALY NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 137. ITALY NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
  • TABLE 138. ITALY NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. ITALY NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 140. NETHERLANDS NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 141. NETHERLANDS NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
  • TABLE 142. NETHERLANDS NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. NETHERLANDS NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 144. NIGERIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 145. NIGERIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
  • TABLE 146. NIGERIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. NIGERIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 148. NORWAY NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 149. NORWAY NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
  • TABLE 150. NORWAY NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. NORWAY NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 152. POLAND NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 153. POLAND NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
  • TABLE 154. POLAND NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. POLAND NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 156. QATAR NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 157. QATAR NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
  • TABLE 158. QATAR NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. QATAR NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 160. RUSSIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 161. RUSSIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
  • TABLE 162. RUSSIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. RUSSIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 164. SAUDI ARABIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 165. SAUDI ARABIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
  • TABLE 166. SAUDI ARABIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. SAUDI ARABIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH AFRICA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 169. SOUTH AFRICA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
  • TABLE 170. SOUTH AFRICA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. SOUTH AFRICA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 172. SPAIN NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 173. SPAIN NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
  • TABLE 174. SPAIN NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. SPAIN NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 176. SWEDEN NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 177. SWEDEN NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
  • TABLE 178. SWEDEN NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. SWEDEN NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 180. SWITZERLAND NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 181. SWITZERLAND NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
  • TABLE 182. SWITZERLAND NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. SWITZERLAND NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 184. TURKEY NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 185. TURKEY NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
  • TABLE 186. TURKEY NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. TURKEY NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED ARAB EMIRATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED ARAB EMIRATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED ARAB EMIRATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED ARAB EMIRATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED KINGDOM NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 193. UNITED KINGDOM NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
  • TABLE 194. UNITED KINGDOM NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 195. UNITED KINGDOM NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 196. NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 197. NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET, FPNV POSITIONING MATRIX, 2023